These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3983465)

  • 1. Evaluation of two distinctive beta-carbolines on serotonin binding in human platelets.
    Taylor DL; Tansey W; Cook JM; Ho BT
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):133-6. PubMed ID: 3983465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of various tryptolines (tetrahydro-beta-carbolines) on 5-hydroxytryptamine receptors.
    Holman RB
    Prog Clin Biol Res; 1982; 90():167-81. PubMed ID: 6287489
    [No Abstract]   [Full Text] [Related]  

  • 3. The uptake of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline and its effect on 5-hydroxytryptamine uptake and release in blood platelets.
    Airaksinen MM; Huang JT; Ho BT; Taylor D; Walker K
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):375-80. PubMed ID: 726902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 6-methoxytetrahydro-beta-carboline on 5-hydroxytryptamine binding in rat brain.
    Taylor DL; Silverman PB; Ho BT
    J Pharm Pharmacol; 1984 Feb; 36(2):125-7. PubMed ID: 6143800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
    Khorana N; Smith C; Herrick-Davis K; Purohit A; Teitler M; Grella B; Dukat M; Glennon RA
    J Med Chem; 2003 Aug; 46(18):3930-7. PubMed ID: 12930153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Tkachenko SE
    Arch Pharm (Weinheim); 2009 Dec; 342(12):740-7. PubMed ID: 19921682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new antagonist of the 5-hydroxytryptamine receptor of blood platelets.
    Laubscher A; Pletscher A; Mester L; Mester M
    Arzneimittelforschung; 1982; 32(6):686-8. PubMed ID: 7202374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
    Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
    Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
    Audia JE; Evrard DA; Murdoch GR; Droste JJ; Nissen JS; Schenck KW; Fludzinski P; Lucaites VL; Nelson DL; Cohen ML
    J Med Chem; 1996 Jul; 39(14):2773-80. PubMed ID: 8709108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of tetrahydro-beta-carbolines with brain serotonin metabolism.
    Buckholtz NS
    Prog Clin Biol Res; 1982; 90():183-90. PubMed ID: 7111318
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of low-affinity serotonin receptors upon storage of human platelets.
    Soslau G; Gillen J; Parker J
    J Cell Physiol; 1988 Dec; 137(3):521-8. PubMed ID: 3192631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB; Oppenheim B
    Neuroscience; 1981; 6(4):801-10. PubMed ID: 7242917
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serotonin distribution between plasma and platelets in clinically healthy children].
    Mello P; Stagni S; Gualandi S; Corsini F
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1062-7. PubMed ID: 7295391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of D-, M- and T-antagonists of serotonin on its absorption by human thrombocytes].
    Oksenkryg GF
    Biull Eksp Biol Med; 1976 Sep; 82(9):1076-7. PubMed ID: 990460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major pharmacological effects of 6-methoxytetrahydro-beta-carboline, a drug elevating the tissue 5-hydroxytryptamine level.
    Airaksinen MM; Ho BT; An R; Taylor D
    Arzneimittelforschung; 1978; 28(1):42-6. PubMed ID: 580196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin binding proteins from human blood platelets. An experimental model system for studies on properties of synaptic vesicles.
    Pignatti PF; Cavalli-Sforza LL
    Neurobiology; 1975 Mar; 5(1):65-74. PubMed ID: 1143606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects.
    Airaksinen MM; Kari I
    Med Biol; 1981 Aug; 59(4):190-211. PubMed ID: 6121956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.